Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
An NFATC4 phospho-switch links matrix stiffness to fibroblast fate
Rebecca Shelley Frabotta, Purushothama Rao Tata
Rebecca Shelley Frabotta, Purushothama Rao Tata
View: Text | PDF
Commentary

An NFATC4 phospho-switch links matrix stiffness to fibroblast fate

  • Text
  • PDF
Abstract

Fibrosis is driven by the activation of quiescent fibroblasts into contractile, matrix-secreting myofibroblasts, a transition governed jointly by biochemical signals and by the mechanical properties of the ECM. How the physical stiffness of tissue is converted into a durable transcriptional cell fate decision has remained poorly understood. In this issue of the JCI, Kadri et al. used global phosphoproteomic profiling of primary human lung fibroblasts across a defined stiffness gradient to identify phosphorylation of NFATC4 at residues S213/S217 as a mechanosensitive switch that is both necessary and sufficient for the fibroblast-to-myofibroblast transition. They validated these predictions in an independent transcriptomic dataset from patients with idiopathic pulmonary fibrosis, showing that NFATC4 expression increased with disease severity. Prior work has implicated NFATC4 activation in cardiac and hepatic fibrosis, suggesting that this single modification may serve as a convergence point for mechanical and cytokine signals across fibrotic diseases.

Authors

Rebecca Shelley Frabotta, Purushothama Rao Tata

×

Figure 1

Matrix stiffness activates an NFATC4 phospho-switch gating the fibroblast-to-myofibroblast transition.

Options: View larger image (or click on image) Download as PowerPoint
Matrix stiffness activates an NFATC4 phospho-switch gating the fibroblas...
Kadri et al. (10) used phosphoproteomic profiling in human lung fibroblasts cultured across a range of physiological matrix stiffnesses to identify mechanosensitive phosphosites involved in fibroblast differentiation. Among the candidates, NFATC4 emerged as a key regulator based on the strong association of its downstream targets with pathological fibrosis. (A) Increasing matrix stiffness promoted JNK-dependent phosphorylation of NFATC4 at S213/S217, enabling NFATC4 nuclear localization and induction of a fibrotic gene program. This stiffness-responsive switch drove CTHRC1+/ACTA2+ myofibroblast commitment, with TGF-β/SMAD2/3 signaling reinforcing the fibrotic state. (B) Kadri et al.’s study doubles as a resource for mechanosensitive phosphosites, adding substantially to those previously reported. This panel highlights select phosphosites spanning a range of roles, including cell adhesion, cytoskeletal reorganization, cell motility, and regulation of transcription.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts